Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum CannaRoyalty Corp C.CRZ

Origin House is a growing cannabis product and brands company operating across key markets in the U.S. and Canada. The company delivers over 130 branded cannabis products to the licensed dispensaries. It provides distribution, manufacturing, cultivation and marketing services for its brand partners. The company operates through two operating segments, The Corporate segment derives income from... see more

CSE:CRZ - Post Discussion

CannaRoyalty Corp > this could be a good move
View:
Post by investalot23 on Apr 01, 2019 9:33pm

this could be a good move

according to there PP. Canopy is worth 22 B fully diluted and cresco lab is 5.4B fully diluted. Canopy only has access to canada whereas cresco has access to both and population of 185 M.  too be honest i am not sure why canopy is soo over valued. what does canopy have that cresco does not? honest opinions
Comment by investalot23 on Apr 01, 2019 9:41pm
is the difference the market? cresco is cnsx and canopy is tsx and nyse. and the big players only invest in tsx and nyse and not cnsx
Comment by VENMan on Apr 01, 2019 9:49pm
Canopy has Cresco Labs market cap in Cash, give or take. What Cresco and Origin House do in sales for a year Canopy does in a quarter. Canopy has moved into international markets, Cresco Labs in just 11 states Canopy landed a Whale, that put $5 Billion in their cash account. Couls add another $7 Billion in cash. Cresco Labs no whale in site. Canopy's Book Value is 3 times more than Cresco Labs ...more  
Comment by Tradertimestwo on Apr 01, 2019 9:52pm
And Canopy has 235 million in losses last quarter. U.S. stocks will be the revenue winners very shortly imo.
Comment by Tradertimestwo on Apr 01, 2019 10:03pm
That number may be incorrect. But Canopy had a 346million loss in last 9 months.....
Comment by investalot23 on Apr 01, 2019 9:58pm
i would say that is not true. estimated revenue is 383 M in 2019. Canopy is doing 20M a quater. canopy has international distribution agreements but not any sales True they have alot of cash but they cant use it on the largest market in the world... the US.  All there cash is sitting on the sidelines. and canopy is burning thru it fast. still not profitable. 
Comment by VENMan on Apr 01, 2019 10:30pm
  Canopy Growth earns $74.86-million in Q3 fiscal 2019 2019-02-15 02:00 ET - News Release Mr. Bruce Linton reports CANOPY GROWTH CORPORATION REPORTS THIRD QUARTER FISCAL 2019 FINANCIAL RESULTS: GROSS SALES OF $98M; NET REVENUE HITS RECORD $83M hey, but think whatever you want, Amazin!    investalot23 - (4/1/2019 9:58:27 PM)   ...more  
Comment by Tradertimestwo on Apr 01, 2019 10:37pm
What i think is Canopy still lost 346 million in last 9 months. Sure they made a lot of revenue too. Not denying that. But a lot of debt to make up. Origin house was well on the way to being net cash flow positive.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities